Requires health insurance policies to include coverage of optional anesthesia for certain contraceptive and menstrual health procedures including, but not limited to, loop electrosurgical excision procedure, colposcopy, ablation, and intrauterine device insertion.
A03645 would amend New York’s insurance law to require most health insurance policies and contracts that already cover contraception and related reproductive health services to also cover optional anesthesia for certain vaginal, cervical, and uterine procedures. The bill specifically names procedures such as loop electrosurgical excision procedure (LEEP), colposcopy, ablation, and intrauterine device (IUD) insertion, and it ties this new requirement to the state’s existing mandates for contraceptive coverage.
The bill also expands the statutory language governing contraceptive coverage by adding references to “menstrual health procedures” alongside contraceptive drugs, devices, and products. It preserves existing rules on coverage of FDA-approved contraceptives, over-the-counter products, emergency contraception, therapeutic equivalents, provider-directed exceptions, and up to a 12-month dispensing supply, while adding the anesthesia requirement to individual, group, blanket, and comprehensive health coverage provisions. The bill would take effect immediately if enacted.
If enacted, the bill would amend sections 3216, 3221, and 4303 of the Insurance Law, affecting individual, group, blanket, and comprehensive health insurance policies issued or renewed in New York. Insurers would be required to cover optional anesthesia for specified gynecological and reproductive procedures without cost-sharing where the underlying contraceptive coverage mandate applies, and the Superintendent of Financial Services would continue to oversee exception processes and related regulations. The bill would therefore expand mandated benefits for insured patients and impose additional coverage obligations on health plans and insurers.
The available record shows no committee transcript or vote history, so there is no documented floor or committee debate to gauge broad sentiment. Based on the bill text and caption, the measure appears to be framed as a patient-access and pain-management expansion for reproductive health care, suggesting a generally supportive policy intent. Because no votes or recorded discussion are provided, there is no evidence of formal opposition or amendment activity in the supplied materials.
The main policy issue likely concerns the cost and scope of mandated insurance coverage, particularly whether insurers should be required to pay for optional anesthesia in procedures that may already be covered without it. Another possible point of contention is the breadth of the new mandate, including the addition of “menstrual health procedures” to existing contraceptive coverage language and the requirement that provider judgment control exceptions for non-covered therapeutic equivalents. No specific objections, supporters, or negotiated compromises are documented in the provided materials.